1
项与 Myeloablative Hematopoietic Stem Cell (Rho Federal Systems Division) 相关的临床试验A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
SCOT is a clinical research study designed for people with severe forms of scleroderma. SCOT stands for Scleroderma: Cyclophosphamide Or Transplantation. The SCOT study will compare the potential benefits of stem cell transplant and high-dose monthly cyclophosphamide (Cytoxan) in the treatment of scleroderma.
100 项与 Myeloablative Hematopoietic Stem Cell (Rho Federal Systems Division) 相关的临床结果
100 项与 Myeloablative Hematopoietic Stem Cell (Rho Federal Systems Division) 相关的转化医学
100 项与 Myeloablative Hematopoietic Stem Cell (Rho Federal Systems Division) 相关的专利(医药)
100 项与 Myeloablative Hematopoietic Stem Cell (Rho Federal Systems Division) 相关的药物交易